Trevox Tablet 500mg

Indication:

Acute maxillary sinusitis, Acute bacterial exacerbation of Chronic bronchitis, Community-acquired pneumonia, Nosocomial Pneumonia,

Complicated urinary tract infections, Uncomplicated UTI, Acute pyelonephritis, Chronic bacterial prostatitis, Uncomplicated &

complicated skin and soft tissue infections including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections.

Inhalation anthrax (post-exposure): To prevent the development of inhalational anthrax following exposure to Bacillus anthracis.

Dosage & Administration:

Acute sinusitis, 500 mg once daily for 10-14 days, Exacerbation of chronic bronchitis, 250-500 mg once daily for 7 days,

Community-acquired pneumonia, 500 mg once daily for 7-14 days, Community-acquired pneumonia, 750 mg once daily for 5 days,

Nosocomial Pneumonia, 750 mg once daily for 7-14 days, Complicated urinary-tract infections and acute pyelonephritis, 250 mg daily

for 7-10 days, Uncomplicated UTI, 250 mg once daily for 3 days, Acute pyelonephritis, 250 mg once daily for 10 days, Chronic

bacterial prostatitis, 500 mg once daily for 28 days, Uncomplicated skin and soft-tissue infections, 500 mg once daily for 7-10

days, Complicated skin and soft-tissue infections, 750 mg once daily for 7-14 days.

Inhalation anthrax (post-exposure): Adult-500 mg once daily for 60 days.

Preparation:

Trevox® 500 tablet: Box contains 3 x 10 tablets in blister strip.

Trevox® 750 tablet: Box contains 2 x 10 tablets in blister strip.